Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia

References

• WolfeFRossKAndersonJRussellIJAspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptomsJ Rheumatol19952211511567699662
   PubMed Web of Science ®Google Scholar
• LawrenceRCFelsonDTHelmickCGEstimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part IIArthritis Rheum2008581263518163497
   PubMed Web of Science ®Google Scholar
• SkaerTLFibromyalgia: disease synopsis, medication cost effectiveness and economic burdenPharmacoeconomics201432545746624504852
   PubMed Web of Science ®Google Scholar
• BuskilaDSarzi-PuttiniPBiology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndromeArthritis Res Ther20068521816887010
   PubMed Web of Science ®Google Scholar
• BennettRMJonesJTurkDCRussellIJMatallanaLAn internet survey of 2,596 people with fibromyalgiaBMC Musculoskelet Disord200782717349056
   PubMed Web of Science ®Google Scholar
• GieseckeTWilliamsDAHarrisRESubgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factorsArthritis Rheum200348102916292214558098
   PubMed Web of Science ®Google Scholar
• TurkDCOkifujiASinclairJDStarzTWPain, disability, and physical functioning in subgroups of patients with fibromyalgiaJ Rheumatol1996237125512628823701
   PubMed Web of Science ®Google Scholar
• MelzackREvolution of the neuromatrix theory of pain. The Prithvi Raj Lecture: presented at the third World Congress of World Institute of Pain, Barcelona 2004Pain Pract200552859417177754
   PubMedGoogle Scholar
• SalaffiFSarzi-PuttiniPGirolimettiRAtzeniFGaspariniSGrassiWHealth-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health surveyClin Exp Rheumatol2009275 Suppl 56S67S7420074443
   PubMed Web of Science ®Google Scholar
• ReichJWOlmstedMEvan PuymbroeckCMIllness uncertainty, partner caregiver burden and support, and relationship satisfaction in fibromyalgia and osteoarthritis patientsArthritis Rheum2006551869316463418
   PubMed Web of Science ®Google Scholar
• JuusoPSkärLOlssonMSöderbergSLiving with a double burden: meanings of pain for women with fibromyalgiaInt J Qual Stud Health Well-being2011637184
   PubMedGoogle Scholar
• McDonaldMDiBonaventuraMdUllmanSMusculoskeletal pain in the workforce: the effects of back, arthritis, and fibromyalgia pain on quality of life and work productivityJ Occup Environ Med201153776577021685799
   PubMed Web of Science ®Google Scholar
• WhiteLABirnbaumHGKaltenboeckATangJMallettDRobinsonRLEmployees with fibromyalgia: medical comorbidity, healthcare costs, and work lossJ Occup Environ Med2008501132418188077
   PubMed Web of Science ®Google Scholar
• MarkkulaRKalsoEHuunan-SeppäläAThe burden of symptoms predicts early retirement: a twin cohort study on fibromyalgia-associated symptomsEur J Pain201115774174721316271
   PubMed Web of Science ®Google Scholar
• WolfeFWalittBTKatzRSHäuserWSocial security work disability and its predictors in patients with fibromyalgiaArthritis Care Res (Hoboken)20146691354136324515531
   PubMed Web of Science ®Google Scholar
• KnightTSchaeferCChandranAZlatevaGWinkelmannAPerrotSHealth-resource use and costs associated with fibromyalgia in France, Germany, and the United StatesClinicoecon Outcomes Res2013517118023637545
   PubMedGoogle Scholar
• BigattiSMHernandezAMCronanTARandKLSleep disturbances in fibromyalgia syndrome: relationship to pain and depressionArthritis Rheum200859796196718576297
   PubMed Web of Science ®Google Scholar
• WinkelmannAPerrotSSchaeferCImpact of fibromyalgia severity on health economic costs: results from a European cross-sectional studyAppl Health Econ Health Policy20119212513621332254
   PubMedGoogle Scholar
• TheadomACropleyM‘This constant being woken up is the worst thing’ – experiences of sleep in fibromyalgia syndromeDisabil Rehabil201032231939194720919892
   PubMed Web of Science ®Google Scholar
• AffleckGUrrowsSTennenHHigginsPAbelesMSequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgiaPain1996682–33633689121825
   PubMed Web of Science ®Google Scholar
• LentzMJLandisCARothermelJShaverJLEffects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged womenJ Rheumatol19992671586159210405949
   PubMed Web of Science ®Google Scholar
• WagnerJSDiBonaventuraMDChandranABCappelleriJCThe association of sleep difficulties with health-related quality of life among patients with fibromyalgiaBMC Musculoskelet Disord20121319923072292
   PubMed Web of Science ®Google Scholar
• MoldofskyHScarisbrickPEnglandRSmytheHMusculoskeletal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjectsPsychosom Med1975374341351169541
   PubMed Web of Science ®Google Scholar
• RothTLankfordDABhadraPWhalenEResnickEMEffect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography studyArthritis Care Res (Hoboken)201264459760622232085
   PubMed Web of Science ®Google Scholar
• TurkDCOkifujiASinclairJDStarzTWDifferential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatmentArthritis Care Res19981153974049830884
   PubMed Web of Science ®Google Scholar
• BoomershineCSCroffordLJA symptom-based approach to pharmacologic management of fibromyalgiaNat Rev Rheumatol20095419119919337283
   PubMed Web of Science ®Google Scholar
• FitzcharlesMASte-MariePAGoldenbergDLNational fibromyalgia guideline advisory panel. Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: executive summaryPain Res Manag201318311912623748251
   PubMed Web of Science ®Google Scholar
• PiechanJLDonevanSDTaylorCPDickersonMRLiZPregabalin, a novel anticonvulsant, analgesic and anxiolytic drug, exhibits class-specific alpha2-delta-1 and alpha2-delta-2 calcium channel subunit bindingSoc Neurosci Abstr 30: 115.11
   Google Scholar
• ErranteLDPetroffOAAcute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrationsSeizure200312530030612810343
   PubMed Web of Science ®Google Scholar
• MichevaKDBuchananJHolzRWSmithSJRetrograde regulation of synaptic vesicle endocytosis and recyclingNat Neurosci20036992593212910242
   PubMed Web of Science ®Google Scholar
• CunninghamMOWoodhallGLThompsonSEDooleyDJJonesRSGDual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitroEur J Neurosci20042061566157615355323
   PubMed Web of Science ®Google Scholar
• BockbraderHNRadulovicLLPosvarELClinical pharmacokinetics of pregabalin in healthy volunteersJ Clin Pharmacol201050894195020147618
   PubMed Web of Science ®Google Scholar
• ChewMLAlveyCWPlotkaAPregabalin controlled-release pharmacokinetics in healthy volunteers: analysis of four multiple-dose randomized clinical pharmacology studiesClin Drug Investig2014349627637
   PubMed Web of Science ®Google Scholar
• SmartAA multi-dimensional model of clinical utilityInt J Qual Health Care200618537738216951425
   PubMed Web of Science ®Google Scholar
• CroffordLJRowbothamMCMeasePJPregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trialArthritis Rheum20055241264127315818684
   PubMed Web of Science ®Google Scholar
• ArnoldLMRussellIJDiriEWA 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgiaJ Pain20089979280518524684
   PubMed Web of Science ®Google Scholar
• MeasePJRussellIJArnoldLMA randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgiaJ Rheumatol200835350251418278830
   PubMed Web of Science ®Google Scholar
• PauerLWinkelmannAArsenaultPAn international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgiaJ Rheumatol201138122643265221965636
   PubMed Web of Science ®Google Scholar
• OhtaHOkaHUsuiCOhkuraMSuzukiMNishiokaKA randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgiaArthritis Res Ther2012145R21723062189
   PubMed Web of Science ®Google Scholar
• CroffordLJMeasePJSimpsonSLFibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalinPain2008136341943118400400
   PubMed Web of Science ®Google Scholar
• OhtaHOkaHUsuiCOhkuraMSuzukiMNishiokaKAn open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgiaMod Rheumatol20132361108111523203241
   PubMed Web of Science ®Google Scholar
• FarrarJTYoungJPJrLaMoreauxLWerthJLPooleRMClinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain200194214915811690728
   PubMed Web of Science ®Google Scholar
• StraubeSDerrySMooreRAMcQuayHJPregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reportsRheumatology (Oxford)201049470671520056767
   PubMed Web of Science ®Google Scholar
• MooreRAStraubeSWiffenPJDerrySMcQuayHJPregabalin for acute and chronic pain in adultsCochrane Database Syst Rev20093CD00707619588419
   PubMed Web of Science ®Google Scholar
• HindmarchIDawsonJStanleyNA double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placeboSleep200528218719316171242
   PubMed Web of Science ®Google Scholar
• ZisapelNNirTDetermination of the minimal clinically significant difference on a patient visual analog sleep quality scaleJ Sleep Res200312429129814633240
   PubMed Web of Science ®Google Scholar
• RussellIJCroffordLJLeonTThe effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndromeSleep Med200910660461019410509
   PubMed Web of Science ®Google Scholar
• CappelleriJCBushmakinAGMcDermottAMMeasurement properties of the medical outcomes study sleep scale in patients with fibromyalgiaSleep Med200910776677019185539
   PubMed Web of Science ®Google Scholar
• ArnoldLMEmirBPauerLResnickMClairATime to improvement of pain and sleep quality in clinical trials of pregabalin for the treatment of fibromyalgiaPain Med201516117618525529830
   PubMed Web of Science ®Google Scholar
• PauerLAtkinsonGMurphyTKPeterselDZeiherBLong-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalinClin J Pain201228760961422688598
   PubMed Web of Science ®Google Scholar
• StraubeSMooreRAPaineJInterference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain responseBMC Musculoskelet Disord20111212521639874
   PubMed Web of Science ®Google Scholar
• ArnoldLMEmirBMurphyTKSafety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgiaClin Ther20123451092110222503162
   PubMed Web of Science ®Google Scholar
• FongTLeeAJPregabalin-associated heart failure decompensation in a patient with a history of stage I heart failureAnn Pharmacother20144881077108124769529
   PubMed Web of Science ®Google Scholar
• ErdoğanGCeyhanDGüleçSPossible heart failure associated with pregabalin use: case reportAgri2011232808321644108
   PubMedGoogle Scholar
• PageRLCantuMLindenfeldJHergottLJLowesBDPossible heart failure exacerbation associated with pregabalin: case discussion and literature reviewJ Cardiovasc Med (Hagerstown)20089992292518695430
   PubMed Web of Science ®Google Scholar
• HoJMTriccoACPerrierLChenMJuurlinkDNStrausSERisk of heart failure and edema associated with the use of pregabalin: a systematic reviewSyst Rev201322523641821
   PubMedGoogle Scholar
• Pfizer IncPregabalin (Lyrica) package insertNew York, NYPfizer2007
   Google Scholar
• LloydABoomershineCSChoyEHChandranAZlatevaGThe cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspectiveJ Med Econ201215348149222339078
   PubMedGoogle Scholar
• ChoyERichardsSBowrinKCost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspectiveCurr Med Res Opin201026496597520178405
   PubMed Web of Science ®Google Scholar
• NeumannPJCohenJTWeinsteinMCUpdating cost-effectiveness – the curious resilience of the US$50,000-per-QALY thresholdN Engl J Med2014371979679725162885
   PubMed Web of Science ®Google Scholar
• KeshavarzKHashemi-MeshkiniAGharibnaseriZNikfarSKebriaeezadehAAbdollahiMA systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experienceArch Med Sci20139696196724482637
   PubMed Web of Science ®Google Scholar
• Arreola OrnelasHRosado BuzzoAGarcíaLDorantes AguilarJContreras HernándezIMould QuevedoJFCost-effectiveness analysis of pharmacologic treatment of fibromyalgia in MexicoReumatol Clin20128312012722386298
   PubMedGoogle Scholar
• ParkerLHuelinRKhankhelZWasiakRMouldJA systematic review of pharmacoeconomic studies for pregabalinPain Pract2015151829424815038
   PubMed Web of Science ®Google Scholar